Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for REMDESIVIR
- An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.
- Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities
- PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
- MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
- MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance
- Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Shionogi Protease Inhibitor
- Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients
- A Study to Compare S-217622 With Placebo in Non-Hospitalized High-Risk Participants With COVID-19
- Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19
- Inhalational Ethanol Therapy (Spray and Nebulized ETHO) in COVID-19 Treatment
- Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
- SOLIDARITY Finland Plus Long COVID-19
- Randomized Study of Efficacy of Different Treatment Regimens of Olokizumab
- Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19
- Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19
- A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia
- A Double-blind Randomized Controlled Trial of Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients
- AV-001 for Hospitalized Patients With COVID-19 Disease
- "Efesovir" (FS-1) for COVID-19, Phase 2
- Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
- Phase 2a MIB-626 vs. Placebo COVID-19
- A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19
- Public Health Emergency: SOLIDARITY TRIAL Philippines
- Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients
- ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19
- SOLIDARITY Finland Long COVID-19
- Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19
- Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus
- Remdesivir- Ivermectin Combination Therapy in Severe Covid-19
- Ivermectin Versus Standard Treatment in Mild COVID-19
- IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.
- Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19
- Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19
- The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients
- Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore
- SARS-CoV-2 Human Challenge Characterisation Study
- Estradiol and Progesterone in Hospitalized COVID-19 Patients
- Hydroxychloroquine for Treatment of Non-Severe COVID-19
- Remdesivir Efficacy In Management Of COVID-19 Patients
- The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms
- ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
- Omega-3 Oil Use in COVID-19 Patients in Qatar
- Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)
- Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes
- Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
- Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection
- Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
- Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients
- Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19
- Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)
- Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
- Antiviral Drugs on the Treatment of SARS-CoV-2
- Survival TRial Using CytoKines in COVID-19 (STRUCK Trial)
- Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients
- Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19
- Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients
- Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal
- Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients
- Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins
- Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home
- Inhaled Ivermectin and COVID-19
- Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial
- Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection
- Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)
- Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19
- IFN-beta 1b and Remdesivir for COVID19
- World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments
- Adaptive COVID-19 Treatment Trial 4 (ACTT-4)
- REMdesivir-HU Clinical Study and Severe Covid-19 Patients
- Treat COVID-19 Patients With Regadenoson
- Angiotensin 1-7 as a Therapy in the Treatment of COVID-19
- Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19)
- Immune Modulators for Treating COVID-19
- ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19
- ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19
- Fostamatinib for Hospitalized Adults With COVID-19
- Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19
- An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
- Remdesivir in COVID-19 Lahore General Hospital
- Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
- Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
- COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7
- Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
- Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection
- CSL324 in COVID-19
- Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia
- ACTIV-3: Therapeutics for Inpatients With COVID-19
- Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting
- Cyclosporine For The Treatment Of COVID-19(+)
- Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan
- Adaptive COVID-19 Treatment Trial 3 (ACTT-3)
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
- Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
- Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement
- DEFINE - Evaluating Therapies for COVID-19
- Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)
- Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19
- A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
- Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
- Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
- Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization
- COVID-19 and Anti-CD14 Treatment Trial
- Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection
- Favipiravir vs Hydroxychloroquine vs Control in COVID -19
- Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19
- Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy
- Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial
- Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19
- Multi-site Adaptive Trials for COVID-19
- COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19
- Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)
- Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia
- Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
- Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
- The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol
- A Study of Auxora in Patients With Severe COVID-19 Pneumonia
- Remdesivir Efficacy in Coronavirus Disease
- Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study
- Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
- The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.
- COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19
- The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
- Norwegian Coronavirus Disease 2019 Study
- Trial of Treatments for COVID-19 in Hospitalized Adults
- Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients
- Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
- Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
- A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
- Adaptive COVID-19 Treatment Trial (ACTT)
- A Trial of Remdesivir in Adults With Severe COVID-19
- A Trial of Remdesivir in Adults With Mild and Moderate COVID-19
- Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
Clinical trials list
click for details